Dr. Reddy’s Lab launches Colesevelam HCI Tablets
Dr. Reddy’s Laboratories has launched Colesevelam HCI Tablets, USP, a therapeutic equivalent generic version of WELCHOL (colesevelam HCI) Tablets in the United States market approved by the US Food and Drug Administration (USFDA). The WELCHOL brand and generic had US sales of around $471 million MAT for the most recent twelve months ending in August … Read more